Study reveals altered neural signature in patients with depression

FHS
July 15, 2024
7:17 pm

As parents, teachers and pet owners can attest, rewards play a huge role in shaping behaviors in humans and animals.

WHO warns of “harmful” fake Ozempic in circulation in Americas and Europe – Pharmaceutical Technology

Three falsified batches of Ozempic have been detected in Brazil, the UK and US. Image credit: Shutterstock/ Marc Bruxelle. The World Health Organization (WHO) has

June 21, 2024

Health Canada approves FYB201/Ranopto® (Ranibizumab), a biosimilar to Lucentis® – Biotech Investments

EQS-News: Formycon AG / Key word(s): Regulatory Approval Health Canada approves FYB201/Ranopto® (Ranibizumab), a biosimilar to Lucentis® 07.12.2023 / 07:30 CET/CEST The issuer is solely

December 8, 2023

Updated: FDA approves Autolus’ CAR-T cell therapy for aggressive blood cancer

US regulators gave the green light to Autolus Therapeutics’ cell therapy for adult B cell precursor acute lymphoblastic leukemia, or B-ALL, that has returned or

November 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.